Pub Date : 2024-10-22DOI: 10.1016/j.jss.2024.09.044
Yu Wang MM, Yuan Xu MM, Fu-Ji Meng MM, Xian-Lei Cai MD, Wei-Ming Yu MD, Miao-Zun Zhang MD
<div><h3>Introduction</h3><div>Distal gastrectomy remains the predominant therapeutic approach for gastric cancer, with digestive tract reconstruction as an integral procedure. The implementation of Braun anastomosis following Billroth II anastomosis is common in distal gastrectomy. This retrospective cohort study evaluated the clinical utility of Braun anastomosis by comparing the outcomes and quality of life between Billroth II (B-II) and Billroth II with Braun (B-IIB) anastomosis in the treatment of gastric cancer.</div></div><div><h3>Methods</h3><div>A retrospective cohort study examined clinical and pathological data from 377 patients who underwent distal gastrectomy for gastric cancer treatment at The Affiliated Lihuili Hospital, Ningbo University, from October 2016 to October 2021.185 patients received B-II anastomosis, while the other 192 received B-IIB anastomosis, forming the B-II and B-IIB groups, respectively. Baseline characteristics, perioperative variables, short-term and long-term complications, and nutritional indicators at 1 mo and 1 y postsurgery were compared across both groups. Additionally, gastric endoscopy results at 6 mo and 1 y postsurgery were evaluated. Quality of life at 1 y postsurgery was assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30.</div></div><div><h3>Results</h3><div>Baseline characteristics between the two groups revealed no statistically significant differences (all <em>P ></em> 0.05), confirming their equivalence. All 377 patients successfully underwent curative distal gastrectomy for gastric cancer without intraoperative procedural modifications. No intraoperative complications or perioperative mortality occurred. Notable differences included extended operative time (222.1 ± 41.0 vs. 199.4 ± 24.9 min, <em>P</em> < 0.001), reduced postoperative nasogastric tube removal time (1.8 ± 0.9 vs. 2.2 ± 1.1 d, <em>P</em> < 0.001), decreased average gastric drainage volume (100.7 ± 35.2 vs. 112.2 ± 32.0 mL, <em>P</em> = 0.001), and increased incidence of internal hernia and ileus (4.7% vs. 1.1% and 8.3% vs. 3.2%, <em>P</em> = 0.038 and <em>P</em> = 0.035) in the B-IIB group compared to the B-II group. No significant differences were observed in estimated blood loss, lymph node dissection, postoperative flatus time, transition to a semiliquid diet, length of hospital stay, or short-term and long-term complications (all <em>P</em> > 0.05). Nutritional assessments conducted 1 mo and 1 y postsurgery indicated no statistically significant differences in body mass index, total protein, and serum albumin levels between the two groups (all <em>P</em> > 0.05). Gastric endoscopy evaluations at 6 mo and 1 y postsurgery, including food residue grade, gastritis severity, extent of gastritis, and bile reflux, demonstrated no significant discrepancies between the groups (all <em>P</em> > 0.05). At the 1-y follow-up, neither group exhibited tumor r
简介:远端胃切除术仍是胃癌的主要治疗方法,消化道重建是其中一项不可或缺的手术。在远端胃切除术中,继比洛氏 II 型吻合术之后采用布劳恩吻合术的情况很普遍。这项回顾性队列研究通过比较比洛斯 II(B-II)和比洛斯 II 加布劳恩(B-IIB)吻合术在胃癌治疗中的疗效和生活质量,评估了布劳恩吻合术的临床实用性:一项回顾性队列研究对2016年10月至2021年10月在宁波大学附属李惠利医院接受远端胃切除术治疗胃癌的377例患者的临床和病理资料进行了研究,其中185例患者接受了B-II吻合术,另外192例患者接受了B-IIB吻合术,分别组成B-II组和B-IIB组。对两组患者的基线特征、围手术期变量、短期和长期并发症以及术后1个月和1年的营养指标进行了比较。此外,还评估了术后6个月和1年的胃内镜检查结果。术后1年的生活质量采用欧洲癌症研究和治疗组织生活质量问卷--核心30进行评估:结果:两组患者的基线特征在统计学上无显著差异(P>0.05),证实了两组患者的等同性。所有377名胃癌患者均成功接受了根治性远端胃切除术,术中未进行任何程序修改。术中未出现并发症或围术期死亡率。显著差异包括手术时间延长(222.1 ± 41.0 分钟 vs. 199.4 ± 24.9 分钟,P 0.05)。术后 1 个月和 1 年的营养评估显示,两组患者的体重指数、总蛋白和血清白蛋白水平差异无统计学意义(均 P > 0.05)。手术后 6 个月和 1 年的胃内镜评估(包括食物残渣等级、胃炎严重程度、胃炎范围和胆汁反流)显示,两组之间没有显著差异(所有 P > 0.05)。在 1 年的随访中,两组患者均未出现肿瘤复发、肿瘤相关疾病死亡、术后并发症或其他疾病。此外,使用欧洲癌症研究和治疗组织生活质量问卷-核心进行的生活质量评估显示,两组在不同领域或项目上没有显著差异(所有P>0.05):结论:B-II和B-IIB吻合术的对比分析表明,术中参数、术后营养结果、胃内镜结果或术后生活质量均无明显差异。不过,采用博朗吻合术会延长手术时间,并可能增加术后内疝的可能性。
{"title":"Comparison Between Billroth II and Billroth II + Braun Anastomosis in Gastrectomy for Gastric Cancer","authors":"Yu Wang MM, Yuan Xu MM, Fu-Ji Meng MM, Xian-Lei Cai MD, Wei-Ming Yu MD, Miao-Zun Zhang MD","doi":"10.1016/j.jss.2024.09.044","DOIUrl":"10.1016/j.jss.2024.09.044","url":null,"abstract":"<div><h3>Introduction</h3><div>Distal gastrectomy remains the predominant therapeutic approach for gastric cancer, with digestive tract reconstruction as an integral procedure. The implementation of Braun anastomosis following Billroth II anastomosis is common in distal gastrectomy. This retrospective cohort study evaluated the clinical utility of Braun anastomosis by comparing the outcomes and quality of life between Billroth II (B-II) and Billroth II with Braun (B-IIB) anastomosis in the treatment of gastric cancer.</div></div><div><h3>Methods</h3><div>A retrospective cohort study examined clinical and pathological data from 377 patients who underwent distal gastrectomy for gastric cancer treatment at The Affiliated Lihuili Hospital, Ningbo University, from October 2016 to October 2021.185 patients received B-II anastomosis, while the other 192 received B-IIB anastomosis, forming the B-II and B-IIB groups, respectively. Baseline characteristics, perioperative variables, short-term and long-term complications, and nutritional indicators at 1 mo and 1 y postsurgery were compared across both groups. Additionally, gastric endoscopy results at 6 mo and 1 y postsurgery were evaluated. Quality of life at 1 y postsurgery was assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30.</div></div><div><h3>Results</h3><div>Baseline characteristics between the two groups revealed no statistically significant differences (all <em>P ></em> 0.05), confirming their equivalence. All 377 patients successfully underwent curative distal gastrectomy for gastric cancer without intraoperative procedural modifications. No intraoperative complications or perioperative mortality occurred. Notable differences included extended operative time (222.1 ± 41.0 vs. 199.4 ± 24.9 min, <em>P</em> < 0.001), reduced postoperative nasogastric tube removal time (1.8 ± 0.9 vs. 2.2 ± 1.1 d, <em>P</em> < 0.001), decreased average gastric drainage volume (100.7 ± 35.2 vs. 112.2 ± 32.0 mL, <em>P</em> = 0.001), and increased incidence of internal hernia and ileus (4.7% vs. 1.1% and 8.3% vs. 3.2%, <em>P</em> = 0.038 and <em>P</em> = 0.035) in the B-IIB group compared to the B-II group. No significant differences were observed in estimated blood loss, lymph node dissection, postoperative flatus time, transition to a semiliquid diet, length of hospital stay, or short-term and long-term complications (all <em>P</em> > 0.05). Nutritional assessments conducted 1 mo and 1 y postsurgery indicated no statistically significant differences in body mass index, total protein, and serum albumin levels between the two groups (all <em>P</em> > 0.05). Gastric endoscopy evaluations at 6 mo and 1 y postsurgery, including food residue grade, gastritis severity, extent of gastritis, and bile reflux, demonstrated no significant discrepancies between the groups (all <em>P</em> > 0.05). At the 1-y follow-up, neither group exhibited tumor r","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 670-678"},"PeriodicalIF":1.8,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-22DOI: 10.1016/j.jss.2024.09.078
Aryan Rafieezadeh MD, Bardiya Zangbar MD, Gabriel Rodriguez PhD, Jordan Kirsch DO, David Samson MS, Ilya Shnaydman MD, Anna Jose MD, Kartik Prabhakaran MD
Background
In recent years, with the introduction of new anticoagulants there has been a rise in their usage among elderly population who are at risk for traumatic brain injury (TBI) at the same time. We assessed the change in use of anticoagulant in elderly trauma patients and its association with TBI outcomes.
Material and Methods
We performed a 5-y retrospective analysis of Trauma Quality Improvement Program (2017-2021) of trauma patients ≥65 y. Patient who had TBI were identified. We queried the preexisting comorbid conditions for anticoagulant use. The primary outcome was mortality, and the secondary outcome was TBI admissions during study period. We conducted a linear regression analysis to assess for trends in data. We also utilized a propensity score matching in 1:1 ratio to compare patients on prehospital anticoagulant versus nonreceivers.
Results
A total of 1,688,157 patients were included. The trend of TBI admission over the study period has been decreasing significantly (P < 0.001). Prehospital anticoagulant use has been increasing over the study period with the slope of 0.078 (P = 0.043). After propensity score matching, patients with TBI who used anticoagulants before hospitalization had a higher mortality rate compared to nonreceivers (9.1% versus 6.8%, P < 0.001). The mortality rate in patients with anticoagulant use decreased from 2017 to 2019 and increased from 2019 to 2021. However this change was not significant in a linear fashion.
Conclusions
Despite increasing trends of anticoagulant usage, which is associated with a higher mortality risk after TBI in elderly, the rate of TBI admissions has been decreasing over the years. Meanwhile, the trend of mortality in patients with anticoagulant use appears to remain unchanged.
{"title":"Decreasing Trends of Traumatic Brain Injury Despite a Surge in Anticoagulant Use in the Elderly","authors":"Aryan Rafieezadeh MD, Bardiya Zangbar MD, Gabriel Rodriguez PhD, Jordan Kirsch DO, David Samson MS, Ilya Shnaydman MD, Anna Jose MD, Kartik Prabhakaran MD","doi":"10.1016/j.jss.2024.09.078","DOIUrl":"10.1016/j.jss.2024.09.078","url":null,"abstract":"<div><h3>Background</h3><div>In recent years, with the introduction of new anticoagulants there has been a rise in their usage among elderly population who are at risk for traumatic brain injury (TBI) at the same time. We assessed the change in use of anticoagulant in elderly trauma patients and its association with TBI outcomes.</div></div><div><h3>Material and Methods</h3><div>We performed a 5-y retrospective analysis of Trauma Quality Improvement Program (2017-2021) of trauma patients ≥65 y. Patient who had TBI were identified. We queried the preexisting comorbid conditions for anticoagulant use. The primary outcome was mortality, and the secondary outcome was TBI admissions during study period. We conducted a linear regression analysis to assess for trends in data. We also utilized a propensity score matching in 1:1 ratio to compare patients on prehospital anticoagulant versus nonreceivers.</div></div><div><h3>Results</h3><div>A total of 1,688,157 patients were included. The trend of TBI admission over the study period has been decreasing significantly (<em>P</em> < 0.001). Prehospital anticoagulant use has been increasing over the study period with the slope of 0.078 (<em>P</em> = 0.043). After propensity score matching, patients with TBI who used anticoagulants before hospitalization had a higher mortality rate compared to nonreceivers (9.1% <em>versus</em> 6.8%, <em>P</em> < 0.001). The mortality rate in patients with anticoagulant use decreased from 2017 to 2019 and increased from 2019 to 2021. However this change was not significant in a linear fashion.</div></div><div><h3>Conclusions</h3><div>Despite increasing trends of anticoagulant usage, which is associated with a higher mortality risk after TBI in elderly, the rate of TBI admissions has been decreasing over the years. Meanwhile, the trend of mortality in patients with anticoagulant use appears to remain unchanged.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 663-669"},"PeriodicalIF":1.8,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-22DOI: 10.1016/j.jss.2024.09.023
Andrei M. Belyaev PhD , Sergey Y. Boldyrev PhD , Pavel A. Myalyuk PhD , Kirill O. Barbukhatty MD , Alexey A. Petrishchev MD , Vladimir A. Porkhanov MD , Oksana S. Bezdenezhnykh MD , Andrei V. Marchenko MD , Nikolay A. Trofimov PhD , Vadim E. Babokin PhD , Daria V. Smirnova MD
Introduction
Existing evidence regarding the impact of hypothermic circulatory arrest (HCA) depth in acute type A aortic dissection (ATAAD) repair lacks robustness concerning blood loss and mortality. We aimed to assess whether using mild and moderate HCA (MMHCA) versus deep and profound HCA (DPHCA) in ATAAD repair is associated with reduced bleeding risk, lower in-hospital mortality, and improved long-term survival.
Methods
This retrospective cohort study spanned from 2003 to 2023. ATAAD repair patients were identified from hospital records, with exclusion criteria applied to those who died before surgery, those with symptoms lasting longer than 14 d, and those who operated on without HCA. Patients in the DPHCA group underwent surgery with HCA (T ≤ 20°C), while those in the MMHCA group had temperatures ranging from 34°C to 20.1°C.
Results
Out of 549 eligible ATAAD patients, the MMHCA group exhibited a reduced rate of chest re-exploration for bleeding (39% versus 14%, P < 0.005), decreased blood loss after surgery (1637 mL versus 1045 mL, P < 0.005), and lower volumes for red blood cell transfusions (1375 mL versus 903 mL, P < 0.005) compared with the DPHCA group. Additionally, the MMHCA group had lower crude and age- and sex-adjusted in-hospital mortality rates, with a mortality rate ratio of 0.65 (P = 0.003). Cox regression analysis revealed a 25% reduction in long-term mortality for the MMHCA group compared with the DPHCA group (hazard ratio = 0.75; P = 0.045).
Conclusions
ATAAD repair using MMHCA and antegrade cerebral perfusion is associated with lower blood loss and improved immediate and long-term survival.
{"title":"Optimizing Therapeutic Hypothermia Depths in Acute Type A Aortic Dissection Repair","authors":"Andrei M. Belyaev PhD , Sergey Y. Boldyrev PhD , Pavel A. Myalyuk PhD , Kirill O. Barbukhatty MD , Alexey A. Petrishchev MD , Vladimir A. Porkhanov MD , Oksana S. Bezdenezhnykh MD , Andrei V. Marchenko MD , Nikolay A. Trofimov PhD , Vadim E. Babokin PhD , Daria V. Smirnova MD","doi":"10.1016/j.jss.2024.09.023","DOIUrl":"10.1016/j.jss.2024.09.023","url":null,"abstract":"<div><h3>Introduction</h3><div>Existing evidence regarding the impact of hypothermic circulatory arrest (HCA) depth in acute type A aortic dissection (ATAAD) repair lacks robustness concerning blood loss and mortality. We aimed to assess whether using mild and moderate HCA (MMHCA) <em>versus</em> deep and profound HCA (DPHCA) in ATAAD repair is associated with reduced bleeding risk, lower in-hospital mortality, and improved long-term survival.</div></div><div><h3>Methods</h3><div>This retrospective cohort study spanned from 2003 to 2023. ATAAD repair patients were identified from hospital records, with exclusion criteria applied to those who died before surgery, those with symptoms lasting longer than 14 d, and those who operated on without HCA. Patients in the DPHCA group underwent surgery with HCA (<em>T</em> ≤ 20°C), while those in the MMHCA group had temperatures ranging from 34°C to 20.1°C.</div></div><div><h3>Results</h3><div>Out of 549 eligible ATAAD patients, the MMHCA group exhibited a reduced rate of chest re-exploration for bleeding (39% <em>versus</em> 14%, <em>P</em> < 0.005), decreased blood loss after surgery (1637 mL <em>versus</em> 1045 mL, <em>P</em> < 0.005), and lower volumes for red blood cell transfusions (1375 mL <em>versus</em> 903 mL, <em>P</em> < 0.005) compared with the DPHCA group. Additionally, the MMHCA group had lower crude and age- and sex-adjusted in-hospital mortality rates, with a mortality rate ratio of 0.65 (<em>P</em> = 0.003). Cox regression analysis revealed a 25% reduction in long-term mortality for the MMHCA group compared with the DPHCA group (hazard ratio = 0.75; <em>P</em> = 0.045).</div></div><div><h3>Conclusions</h3><div>ATAAD repair using MMHCA and antegrade cerebral perfusion is associated with lower blood loss and improved immediate and long-term survival.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 636-644"},"PeriodicalIF":1.8,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-22DOI: 10.1016/j.jss.2024.09.031
Kylie Callier MD , Michael J. Littau MD , Justin M. Cirone MD , Marion C. Henry MD, MPh , David Hampton MD, Meng , Ashley Wolf MD, MS
Objective
In 2022, firearms injured or killed more than 6000 American children. Significant disparities exist in injury risk. We hypothesized that analyzing an injury's time, date, and location could help identify additional risk and protective factors in the pediatric population.
Methods
We performed a retrospective analysis of the 2003-2020 National Violent Death Reporting System. The National Violent Death Reporting System currently collects data from all 50 states, the District of Columbia, and Puerto Rico. Demographic (age, sex, race/ethnicity) and incident (date, time, location) data were abstracted. Inclusion criteria were pediatric victims (age≤18) of fatal firearm injuries. Records with missing values were excluded. Chi-squared tests were used to test the association between victim demographics and time, date, or location. Significance was P < 0.05.
Results
Nine thousand fifty-eight children (male: 83.5% [n = 7559]), age: 17 yrs old (interquartile range: 15-18 years old), Black: 64.1% [n = 5810]) were eligible. 6161 (68.1%) of children had not completed high school. 3308 (36.5%) fatal injuries occurred after school or at night (1601-2359 h). 3678 (40.6%) injuries occurred at home. Black children were significantly more likely to be injured during the summer months (June – August, P < 0.01), after school or at night (P < 0.001), and along a street (P < 0.001). Hispanic children were more likely to be killed after school or at night (P < 0.001) and along a street (P < 0.001). There was no seasonal variation in this demographic. Compared to other times of the day, there was a significant increase in weekend (Friday-Sunday) morning (0000- 0800) injuries. (P < 0.001).
Conclusions
Firearm violence disproportionately impacts Black children. There are significant associations with the time and season. Interventions during those times such as extended academic engagement or after school programs beyond the traditional school day and school year may afford opportunities which could mitigate exposure to firearm violence.
{"title":"Fatal Pediatric Firearm Injuries: When and Where are Children at Risk?","authors":"Kylie Callier MD , Michael J. Littau MD , Justin M. Cirone MD , Marion C. Henry MD, MPh , David Hampton MD, Meng , Ashley Wolf MD, MS","doi":"10.1016/j.jss.2024.09.031","DOIUrl":"10.1016/j.jss.2024.09.031","url":null,"abstract":"<div><h3>Objective</h3><div>In 2022, firearms injured or killed more than 6000 American children. Significant disparities exist in injury risk. We hypothesized that analyzing an injury's time, date, and location could help identify additional risk and protective factors in the pediatric population.</div></div><div><h3>Methods</h3><div>We performed a retrospective analysis of the 2003-2020 National Violent Death Reporting System. The National Violent Death Reporting System currently collects data from all 50 states, the District of Columbia, and Puerto Rico. Demographic (age, sex, race/ethnicity) and incident (date, time, location) data were abstracted. Inclusion criteria were pediatric victims (age≤18) of fatal firearm injuries. Records with missing values were excluded. Chi-squared tests were used to test the association between victim demographics and time, date, or location. Significance was <em>P</em> < 0.05.</div></div><div><h3>Results</h3><div>Nine thousand fifty-eight children (male: 83.5% [<em>n</em> = 7559]), age: 17 yrs old (interquartile range: 15-18 years old), Black: 64.1% [<em>n</em> = 5810]) were eligible. 6161 (68.1%) of children had not completed high school. 3308 (36.5%) fatal injuries occurred after school or at night (1601-2359 h). 3678 (40.6%) injuries occurred at home. Black children were significantly more likely to be injured during the summer months (June – August, <em>P</em> < 0.01), after school or at night (<em>P</em> < 0.001), and along a street (<em>P</em> < 0.001). Hispanic children were more likely to be killed after school or at night (<em>P</em> < 0.001) and along a street (<em>P</em> < 0.001). There was no seasonal variation in this demographic. Compared to other times of the day, there was a significant increase in weekend (Friday-Sunday) morning (0000- 0800) injuries. (<em>P</em> < 0.001).</div></div><div><h3>Conclusions</h3><div>Firearm violence disproportionately impacts Black children. There are significant associations with the time and season. Interventions during those times such as extended academic engagement or after school programs beyond the traditional school day and school year may afford opportunities which could mitigate exposure to firearm violence.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 645-651"},"PeriodicalIF":1.8,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-22DOI: 10.1016/j.jss.2024.09.052
Maria P. Cote MD , Jorge L. Gomez-Mayorga MD , Natalia Chaves MD, MPH , Jordan M. Broekhuis MD, MPH , Megan C. Mcnichol MLS, AHIP , Q. Lina Hu MD, MS , Benjamin C. James MD, MS
Introduction
Online websites are a major source of educational material for patients undergoing thyroidectomy. We hypothesize that thyroidectomy websites have low quality and are written above the 6th grade readability recommendation.
Methods
A systematic literature review of studies evaluating readability and/or quality of thyroidectomy-informing, English-written websites was performed in November 2023 in three major online databases (Embase, PubMed, and Web of Science).
Results
Ten out of 2017 initially screened studies met the inclusion criteria. All studies found websites’ readability above the recommended 6th grade level. Quality was heterogeneously defined and evaluated by seven of the included studies. Nonetheless, all studies deemed most thyroidectomy websites quality as poor to fair.
Conclusions
Websites addressing thyroidectomy do not meet the recommended readability level for patient educational material. The heterogeneity of scoring and reporting of quality limits comparability. This study highlights the necessity of revising and modifying existing websites to adequately aid patient decision-making.
简介在线网站是甲状腺切除术患者教育材料的主要来源。我们推测甲状腺切除术网站的质量较低,其可读性高于六年级的建议水平:2023年11月,我们在三大在线数据库(Embase、PubMed和Web of Science)中对评估甲状腺切除术英文网站可读性和/或质量的研究进行了系统性文献综述:在初步筛选的 2017 项研究中,有 10 项符合纳入标准。所有研究均发现网站的可读性高于建议的六年级水平。七项纳入研究对质量的定义和评价不尽相同。尽管如此,所有研究都认为大多数甲状腺切除术网站的质量为差到一般:结论:针对甲状腺切除术的网站不符合推荐的患者教育材料可读性水平。质量评分和报告的异质性限制了可比性。本研究强调了修订和修改现有网站的必要性,以充分帮助患者做出决策。
{"title":"Readability and Quality Evaluation of Thyroidectomy Websites: A Systematic Review","authors":"Maria P. Cote MD , Jorge L. Gomez-Mayorga MD , Natalia Chaves MD, MPH , Jordan M. Broekhuis MD, MPH , Megan C. Mcnichol MLS, AHIP , Q. Lina Hu MD, MS , Benjamin C. James MD, MS","doi":"10.1016/j.jss.2024.09.052","DOIUrl":"10.1016/j.jss.2024.09.052","url":null,"abstract":"<div><h3>Introduction</h3><div>Online websites are a major source of educational material for patients undergoing thyroidectomy. We hypothesize that thyroidectomy websites have low quality and are written above the 6<sup>th</sup> grade readability recommendation.</div></div><div><h3>Methods</h3><div>A systematic literature review of studies evaluating readability and/or quality of thyroidectomy-informing, English-written websites was performed in November 2023 in three major online databases (Embase, PubMed, and Web of Science).</div></div><div><h3>Results</h3><div>Ten out of 2017 initially screened studies met the inclusion criteria. All studies found websites’ readability above the recommended 6th grade level. Quality was heterogeneously defined and evaluated by seven of the included studies. Nonetheless, all studies deemed most thyroidectomy websites quality as poor to fair.</div></div><div><h3>Conclusions</h3><div>Websites addressing thyroidectomy do not meet the recommended readability level for patient educational material. The heterogeneity of scoring and reporting of quality limits comparability. This study highlights the necessity of revising and modifying existing websites to adequately aid patient decision-making.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 652-662"},"PeriodicalIF":1.8,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-21DOI: 10.1016/j.jss.2024.09.064
Armaun D. Rouhi BA , Sebastian Leon MD , Jeffrey L. Roberson MD, MBA , Lauren A. Shreve MD, MBA , Gregory J. Nadolski MD , Noel N. Williams MD , Kristoffel R. Dumon MD
Introduction
Enteral nutrition is commonly placed via percutaneous endoscopic gastrostomy (PEG) or radiologically inserted gastrostomy (RIG) techniques. This study compared perioperative outcomes of PEG and RIG in adults with dysphagia caused by cerebral infarction.
Methods
Adult stroke patients who underwent either PEG or RIG between 2018 and 2020 at a tertiary care center were reviewed retrospectively. Differences in baseline characteristics between PEG and RIG patients were adjusted using entropy-balanced weights. Multivariable weighted logistic and linear regressions were subsequently developed to evaluate the independent association between RIG and outcomes of interest.
Results
217 stroke patients met inclusion criteria, of whom 37 (17.0%) received PEG and 180 (83.0%) received RIG. Compared to PEG, patients with RIG were more commonly Medicare beneficiaries and had a higher burden of comorbidities as measured by the Charlson comorbidity index. Time to achieve goal feeds was comparable between PEG and RIG (3 d [interquartile range 2-5] vs 4 d [interquartile range 3-5], respectively, P = 0.059). After multivariate adjustment, RIG was associated with significantly lower odds of reoperation (adjusted odds ratio [AOR] 0.10, 95% CI 0.02-0.50, P = 0.005), cerebrovascular accident (AOR 0.24, 95% CI 0.00-0.74, P = 0.030), and intensive care unit admission (AOR 0.14, 95% CI 0.03-0.70, P = 0.017). Risk factors for in-hospital mortality among RIG included arrhythmia (AOR 6.54, 95% CI 1.67-15.48, P = 0.009), myocardial infarction (AOR 4.78, 95% CI 2.25-10.23, P = 0.009), and obesity (AOR 4.48, 95% CI 1.03-9.61, P = 0.047).
Conclusions
While both techniques are effective methods of enteral feeding in stroke patients, RIG may confer lower perioperative morbidity. Local referral patterns and individual patient comorbidities could influence outcomes following PEG or RIG, necessitating careful patient selection.
导言:肠内营养通常通过经皮内镜胃造口术(PEG)或放射学插入胃造口术(RIG)技术进行。本研究比较了 PEG 和 RIG 对因脑梗塞导致吞咽困难的成人患者的围手术期疗效:回顾性研究了 2018 年至 2020 年期间在一家三级医疗中心接受 PEG 或 RIG 治疗的成人脑卒中患者。使用熵平衡权重调整了 PEG 和 RIG 患者的基线特征差异。结果:217 名卒中患者符合纳入标准,其中 37 人(17.0%)接受了 PEG,180 人(83.0%)接受了 RIG。与 PEG 相比,接受 RIG 的患者更多是医疗保险受益人,而且根据 Charlson 合并症指数衡量,合并症负担更重。PEG 和 RIG 达到进食目标的时间相当(分别为 3 d [四分位间范围 2-5] vs 4 d [四分位间范围 3-5],P = 0.059)。经多变量调整后,RIG 与较低的再次手术几率(调整几率比 [AOR] 0.10,95% CI 0.02-0.50,P = 0.005)、脑血管意外(AOR 0.24,95% CI 0.00-0.74,P = 0.030)和入住重症监护室(AOR 0.14,95% CI 0.03-0.70,P = 0.017)显著相关。RIG患者院内死亡的风险因素包括心律失常(AOR 6.54,95% CI 1.67-15.48,P = 0.009)、心肌梗死(AOR 4.78,95% CI 2.25-10.23,P = 0.009)和肥胖(AOR 4.48,95% CI 1.03-9.61,P = 0.047):虽然两种技术都是中风患者肠内喂养的有效方法,但 RIG 可降低围手术期的发病率。当地的转诊模式和患者的个体合并症可能会影响 PEG 或 RIG 的治疗效果,因此必须谨慎选择患者。
{"title":"Comparison of Gastrostomy Techniques in Stroke Patients With Dysphagia: An Entropy-Balanced Analysis","authors":"Armaun D. Rouhi BA , Sebastian Leon MD , Jeffrey L. Roberson MD, MBA , Lauren A. Shreve MD, MBA , Gregory J. Nadolski MD , Noel N. Williams MD , Kristoffel R. Dumon MD","doi":"10.1016/j.jss.2024.09.064","DOIUrl":"10.1016/j.jss.2024.09.064","url":null,"abstract":"<div><h3>Introduction</h3><div>Enteral nutrition is commonly placed via percutaneous endoscopic gastrostomy (PEG) or radiologically inserted gastrostomy (RIG) techniques. This study compared perioperative outcomes of PEG and RIG in adults with dysphagia caused by cerebral infarction.</div></div><div><h3>Methods</h3><div>Adult stroke patients who underwent either PEG or RIG between 2018 and 2020 at a tertiary care center were reviewed retrospectively. Differences in baseline characteristics between PEG and RIG patients were adjusted using entropy-balanced weights. Multivariable weighted logistic and linear regressions were subsequently developed to evaluate the independent association between RIG and outcomes of interest.</div></div><div><h3>Results</h3><div>217 stroke patients met inclusion criteria, of whom 37 (17.0%) received PEG and 180 (83.0%) received RIG. Compared to PEG, patients with RIG were more commonly Medicare beneficiaries and had a higher burden of comorbidities as measured by the Charlson comorbidity index. Time to achieve goal feeds was comparable between PEG and RIG (3 d [interquartile range 2-5] vs 4 d [interquartile range 3-5], respectively, <em>P</em> = 0.059). After multivariate adjustment, RIG was associated with significantly lower odds of reoperation (adjusted odds ratio [AOR] 0.10, 95% CI 0.02-0.50, <em>P</em> = 0.005), cerebrovascular accident (AOR 0.24, 95% CI 0.00-0.74, <em>P</em> = 0.030), and intensive care unit admission (AOR 0.14, 95% CI 0.03-0.70, <em>P</em> = 0.017). Risk factors for in-hospital mortality among RIG included arrhythmia (AOR 6.54, 95% CI 1.67-15.48, <em>P</em> = 0.009), myocardial infarction (AOR 4.78, 95% CI 2.25-10.23, <em>P</em> = 0.009), and obesity (AOR 4.48, 95% CI 1.03-9.61, <em>P</em> = 0.047).</div></div><div><h3>Conclusions</h3><div>While both techniques are effective methods of enteral feeding in stroke patients, RIG may confer lower perioperative morbidity. Local referral patterns and individual patient comorbidities could influence outcomes following PEG or RIG, necessitating careful patient selection.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 579-586"},"PeriodicalIF":1.8,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-21DOI: 10.1016/j.jss.2024.08.026
Srinithya R. Gillipelli BA , Sarah E. Peiffer MD, MPH , Shannon M. Larabee MD , Pamela Ketwaroo MD , Kristy L. Rialon MD , Joshua Bedwell MD , Deepak Mehta MD , Timothy C. Lee MD , Sundeep G. Keswani MD , Alice King MD
Introduction
Cervicofacial lymphatic malformations (cf-LM) may be identified on prenatal ultrasound, prompting consideration of ex utero intrapartum treatment (EXIT) to secure the fetal airway. Furthermore, the recent shift in postnatal management of cf-LM from resection alone toward a multimodal approach including sirolimus and sclerotherapy may impact the neonatal outcomes of cf-LM. This study aims to characterize the neonatal outcomes of patients with prenatally diagnosed cf-LM who underwent EXIT-to-airway.
Methods
Retrospective, single-center review of all patients who underwent EXIT-to-airway for cf-LM (2011-2020) was performed. Demographics, prenatal imaging, intraoperative details, and outcomes were analyzed using descriptive statistics (median [interquartile range]).
Results
Six patients with prenatally diagnosed cf-LM underwent EXIT-to-airway at a median gestational age of 36 (33.8-36.9) wk. The median volume on fetal magnetic resonance imaging was 187.5 mL (142.3-237.8) and median tracheoesophageal displacement index was 11 mL (9.25-15). All were successfully intubated on placental support with a median duration of 25 (15.25-91) d. There was one fatality at day of life 10 due to necrotizing enterocolitis totalis. Among survivors, 2 of 5 underwent tracheostomy placement, 4 of 5 underwent gastrostomy tubes placement, and all 5 received sirolimus at day of life of 9 [8-10] d. Four patients underwent debulking or excision of their cf-LM during the initial hospitalization. Patients had a median length of stay of 68 (45-129) d. One patient experi enced a pneumothorax with evidence of barotrauma following EXIT-to-airway requiring chest tube placement (duration 8 d).
Conclusions
EXIT-to-airway procedure remains a feasible strategy for mitigating neonatal hypoxia in cases of prenatally diagnosed cervicofacial lymphatic malformations. However, postnatal outcomes are variable with potential long-term aerodigestive sequelae.
{"title":"Ex Utero Intrapartum Treatment for Prenatally Diagnosed Cervicofacial Lymphatic Malformations","authors":"Srinithya R. Gillipelli BA , Sarah E. Peiffer MD, MPH , Shannon M. Larabee MD , Pamela Ketwaroo MD , Kristy L. Rialon MD , Joshua Bedwell MD , Deepak Mehta MD , Timothy C. Lee MD , Sundeep G. Keswani MD , Alice King MD","doi":"10.1016/j.jss.2024.08.026","DOIUrl":"10.1016/j.jss.2024.08.026","url":null,"abstract":"<div><h3>Introduction</h3><div>Cervicofacial lymphatic malformations (cf-LM) may be identified on prenatal ultrasound, prompting consideration of ex utero intrapartum treatment (EXIT) to secure the fetal airway. Furthermore, the recent shift in postnatal management of cf-LM from resection alone toward a multimodal approach including sirolimus and sclerotherapy may impact the neonatal outcomes of cf-LM. This study aims to characterize the neonatal outcomes of patients with prenatally diagnosed cf-LM who underwent EXIT-to-airway.</div></div><div><h3>Methods</h3><div>Retrospective, single-center review of all patients who underwent EXIT-to-airway for cf-LM (2011-2020) was performed. Demographics, prenatal imaging, intraoperative details, and outcomes were analyzed using descriptive statistics (median [interquartile range]).</div></div><div><h3>Results</h3><div>Six patients with prenatally diagnosed cf-LM underwent EXIT-to-airway at a median gestational age of 36 (33.8-36.9) wk. The median volume on fetal magnetic resonance imaging was 187.5 mL (142.3-237.8) and median tracheoesophageal displacement index was 11 mL (9.25-15). All were successfully intubated on placental support with a median duration of 25 (15.25-91) d. There was one fatality at day of life 10 due to necrotizing enterocolitis totalis. Among survivors, 2 of 5 underwent tracheostomy placement, 4 of 5 underwent gastrostomy tubes placement, and all 5 received sirolimus at day of life of 9 [8-10] d. Four patients underwent debulking or excision of their cf-LM during the initial hospitalization. Patients had a median length of stay of 68 (45-129) d. One patient experi enced a pneumothorax with evidence of barotrauma following EXIT-to-airway requiring chest tube placement (duration 8 d).</div></div><div><h3>Conclusions</h3><div>EXIT-to-airway procedure remains a feasible strategy for mitigating neonatal hypoxia in cases of prenatally diagnosed cervicofacial lymphatic malformations. However, postnatal outcomes are variable with potential long-term aerodigestive sequelae.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 628-635"},"PeriodicalIF":1.8,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-21DOI: 10.1016/j.jss.2024.09.065
Christopher Stone MD, Dwight D. Harris MD, Mark Broadwin MD, Sharif A. Sabe MD, Krishna Bellam BS, Meghamsh Kanuparthy MD, M. Ruhul Abid MD, PhD, Frank W. Sellke MD
Introduction
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have shown efficacy in the context of heart failure but have not been well-studied in ischemic heart disease. We employed a large animal model of chronic coronary artery disease and metabolic syndrome (MS) to investigate the hemodynamic and metabolic consequences of SGLT2i administration.
Methods
Thirty-eight Yorkshire swine were divided into two groups, with half (n = 21) receiving a high fat diet to induce MS, and the other half fed a standard diet (n = 17). All animals underwent thoracotomy for ameroid constrictor placement over the left circumflex coronary artery. Treatment with SGLT2i was then initiated, generating four groups: regular diet placebo (CON, n = 9), regular diet canagliflozin (n = 8), high-fat control (n = 11), and high-fat canagliflozin (n = 10). After 5 wks, all animals underwent terminal myocardial harvest with pressure-volume loop acquisition, perfusion studies, and tissue resection for molecular analysis.
Results
SGLT2i improved multiple measures of myocardial performance, including a nearly 1.5-fold increase in both cardiac output and ejection fraction; these changes were associated with augmented capillary density and a twofold increase perfusion to the ischemic myocardium. These augmentations were blunted; however, in the presence of MS, and associated with modulated myocardial expression of multiple major metabolic enzymes.
Conclusions
SGLT2i significantly improved cardiac function in our large animal model of coronary artery disease, with metabolic modulation of the myocardial tissue serving as a candidate account of these changes. The blunting seen with MS underscores the dependence of clinical translatability on faithful representation of the biochemical environment of human disease.
{"title":"Sodium-Glucose Cotransporter-2 Inhibition Normalizes Metabolic Derangements in the Ischemic Myocardium","authors":"Christopher Stone MD, Dwight D. Harris MD, Mark Broadwin MD, Sharif A. Sabe MD, Krishna Bellam BS, Meghamsh Kanuparthy MD, M. Ruhul Abid MD, PhD, Frank W. Sellke MD","doi":"10.1016/j.jss.2024.09.065","DOIUrl":"10.1016/j.jss.2024.09.065","url":null,"abstract":"<div><h3>Introduction</h3><div>Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have shown efficacy in the context of heart failure but have not been well-studied in ischemic heart disease. We employed a large animal model of chronic coronary artery disease and metabolic syndrome (MS) to investigate the hemodynamic and metabolic consequences of SGLT2i administration.</div></div><div><h3>Methods</h3><div>Thirty-eight Yorkshire swine were divided into two groups, with half (<em>n</em> = 21) receiving a high fat diet to induce MS, and the other half fed a standard diet (<em>n</em> = 17). All animals underwent thoracotomy for ameroid constrictor placement over the left circumflex coronary artery. Treatment with SGLT2i was then initiated, generating four groups: regular diet placebo (CON, <em>n</em> = 9), regular diet canagliflozin (<em>n</em> = 8), high-fat control (<em>n</em> = 11), and high-fat canagliflozin (<em>n</em> = 10). After 5 wks, all animals underwent terminal myocardial harvest with pressure-volume loop acquisition, perfusion studies, and tissue resection for molecular analysis.</div></div><div><h3>Results</h3><div>SGLT2i improved multiple measures of myocardial performance, including a nearly 1.5-fold increase in both cardiac output and ejection fraction; these changes were associated with augmented capillary density and a twofold increase perfusion to the ischemic myocardium. These augmentations were blunted; however, in the presence of MS, and associated with modulated myocardial expression of multiple major metabolic enzymes.</div></div><div><h3>Conclusions</h3><div>SGLT2i significantly improved cardiac function in our large animal model of coronary artery disease, with metabolic modulation of the myocardial tissue serving as a candidate account of these changes. The blunting seen with MS underscores the dependence of clinical translatability on faithful representation of the biochemical environment of human disease.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 600-612"},"PeriodicalIF":1.8,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-21DOI: 10.1016/j.jss.2024.09.046
Yiyang Min MS , Kuinan Tong MS , Huajun Lin PhD , Dong Wang PhD , Wei Guo PhD , Shun Li PhD , Zhongtao Zhang PhD
Background
We compared overall survival (OS) and disease-free survival (DFS) for hepatocellular carcinoma (HCC) following radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and liver resection (LR), with the aim of evaluating treatment plans for early-stage HCC.
Methods
Studies in PubMed, Web of Science, and Cochrane databases from April 1, 2004, to April 1, 2024, were searched. Articles were evaluated for quality using the randomized controlled trials tool. Two tool and the Newcastle–Ottawa Scale. Data obtained from the literature were netted using Stata 15.0 and r 4.2.3. The assessed primary outcomes were OS and DFS at 1 and 3 y.
Results
A total of 25 publications with 4548 patients were included, including 13 studies in mainland China and 12 in other regions. For 1-y DFS, the hazard ratio (HR) was 0.54 (95% credible interval (CrI): 0.38–0.76) for LR compared with RFA and 0.57 (95% CrI: 0.3–-0.82) for LR compared with MWA. For 3-y DFS, the HR was 0.52 (95% CrI: 0.38-0.72) for LR compared with RFA and 0.53 (95% CrI: 0.37–0.76). In the Chinese mainland, LR may have a better 1- and 3-y DFS than MWA, but similar survival to RFA. In the other regions, LR had a better DFS than MWA and RFA patients. The rest of the comparisons were not statistically significant.
Conclusions
For early-stage HCC, LR may be more effective in reducing tumor recurrence than ablative treatments. Cryoablation may be a potential treatment for HCC. The differences in treatment effectiveness in different regions are worth further study.
{"title":"Ablative Treatments and Surgery for Early-Stage Hepatocellular Carcinoma: A Network Meta-Analysis","authors":"Yiyang Min MS , Kuinan Tong MS , Huajun Lin PhD , Dong Wang PhD , Wei Guo PhD , Shun Li PhD , Zhongtao Zhang PhD","doi":"10.1016/j.jss.2024.09.046","DOIUrl":"10.1016/j.jss.2024.09.046","url":null,"abstract":"<div><h3>Background</h3><div>We compared overall survival (OS) and disease-free survival (DFS) for hepatocellular carcinoma (HCC) following radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and liver resection (LR), with the aim of evaluating treatment plans for early-stage HCC.</div></div><div><h3>Methods</h3><div>Studies in PubMed, Web of Science, and Cochrane databases from April 1, 2004, to April 1, 2024, were searched. Articles were evaluated for quality using the randomized controlled trials tool. Two tool and the Newcastle–Ottawa Scale. Data obtained from the literature were netted using Stata 15.0 and <em>r</em> 4.2.3. The assessed primary outcomes were OS and DFS at 1 and 3 y.</div></div><div><h3>Results</h3><div>A total of 25 publications with 4548 patients were included, including 13 studies in mainland China and 12 in other regions. For 1-y DFS, the hazard ratio (HR) was 0.54 (95% credible interval (CrI): 0.38–0.76) for LR compared with RFA and 0.57 (95% CrI: 0.3–-0.82) for LR compared with MWA. For 3-y DFS, the HR was 0.52 (95% CrI: 0.38-0.72) for LR compared with RFA and 0.53 (95% CrI: 0.37–0.76). In the Chinese mainland, LR may have a better 1- and 3-y DFS than MWA, but similar survival to RFA. In the other regions, LR had a better DFS than MWA and RFA patients. The rest of the comparisons were not statistically significant.</div></div><div><h3>Conclusions</h3><div>For early-stage HCC, LR may be more effective in reducing tumor recurrence than ablative treatments. Cryoablation may be a potential treatment for HCC. The differences in treatment effectiveness in different regions are worth further study.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 587-599"},"PeriodicalIF":1.8,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-21DOI: 10.1016/j.jss.2024.09.059
Lourenço Sbragia MD, PhD , Igor José Nogueira Gualberto MD , Jason Xia MD , Rahul Gadde MD , Angela Saulsbery MA , Sophia Hameedi MD , Ana Laura Ferreira Mársico Dalto MD, PhD , Oluyinka O. Olutoye MD, PhD
Introduction
Necrotizing enterocolitis (NEC) is a severe inflammatory disease of the gastrointestinal tract and one of the most common life-threatening emergencies affecting newborns. Intestinal fatty acid–binding protein (I-FABP) has been used as a possible marker of intestinal damage in NEC. We aimed to carry out a scoping review of all publications that explore the role of I-FABP in NEC to inspire new research into the potential utility of I-FABP as a marker of NEC.
Methods
We searched for relevant publications using the keywords “necrotizing enterocolitis,” “intestinal fatty acid binding protein,” “NEC,” and “I-FABP” in the National Library of Medicine (PubMed/MEDLINE), Embase, SCOPUS, and Web of Science. Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews was used for reporting findings.
Results
We identified 61 relevant articles, which we divided into clinical (n = 47) and experimental (n = 14) groups.
Conclusions
I-FABP is a promising marker of NEC, especially for NEC stage 2 and 3. Urinary I-FABP follows the same patterns as serum and plasma I-FABP. The definitive roles of I-FABP in early diagnosis of NEC, differential diagnosis in breast feeding, alimentary intolerance, and screening of surgical NEC need clarification and remain a challenge to investigators.
简介坏死性小肠结肠炎(NEC)是一种严重的胃肠道炎症性疾病,也是影响新生儿生命的最常见急症之一。肠道脂肪酸结合蛋白(I-FABP)已被用作 NEC 肠道损伤的可能标志物。我们的目的是对所有探讨 I-FABP 在 NEC 中作用的出版物进行一次范围审查,以激发对 I-FABP 作为 NEC 标志物的潜在效用的新研究:我们在美国国家医学图书馆(PubMed/MEDLINE)、Embase、SCOPUS 和 Web of Science 中使用关键词 "坏死性小肠结肠炎"、"肠脂肪酸结合蛋白"、"NEC "和 "I-FABP "搜索相关出版物。报告结果时使用了《系统综述和元分析首选报告项目》的扩展版(SCOPUS):我们确定了 61 篇相关文章,并将其分为临床组(47 篇)和实验组(14 篇):结论:I-FABP 是一种很有前景的 NEC 标志物,尤其适用于 NEC 2 期和 3 期。尿 I-FABP 与血清和血浆 I-FABP 的变化规律相同。I-FABP 在 NEC 早期诊断、母乳喂养鉴别诊断、消化道不耐受和手术 NEC 筛查中的明确作用需要明确,这仍是研究人员面临的挑战。
{"title":"Intestinal Fatty Acid–Binding Protein as a Marker of Necrotizing Enterocolitis Incidence and Severity: A Scoping Review","authors":"Lourenço Sbragia MD, PhD , Igor José Nogueira Gualberto MD , Jason Xia MD , Rahul Gadde MD , Angela Saulsbery MA , Sophia Hameedi MD , Ana Laura Ferreira Mársico Dalto MD, PhD , Oluyinka O. Olutoye MD, PhD","doi":"10.1016/j.jss.2024.09.059","DOIUrl":"10.1016/j.jss.2024.09.059","url":null,"abstract":"<div><h3>Introduction</h3><div>Necrotizing enterocolitis (NEC) is a severe inflammatory disease of the gastrointestinal tract and one of the most common life-threatening emergencies affecting newborns. Intestinal fatty acid–binding protein (I-FABP) has been used as a possible marker of intestinal damage in NEC. We aimed to carry out a scoping review of all publications that explore the role of I-FABP in NEC to inspire new research into the potential utility of I-FABP as a marker of NEC.</div></div><div><h3>Methods</h3><div>We searched for relevant publications using the keywords “necrotizing enterocolitis,” “intestinal fatty acid binding protein,” “NEC,” and “I-FABP” in the National Library of Medicine (PubMed/MEDLINE), Embase, SCOPUS, and Web of Science. Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews was used for reporting findings.</div></div><div><h3>Results</h3><div>We identified 61 relevant articles, which we divided into clinical (<em>n</em> = 47) and experimental (<em>n</em> = 14) groups.</div></div><div><h3>Conclusions</h3><div>I-FABP is a promising marker of NEC, especially for NEC stage 2 and 3. Urinary I-FABP follows the same patterns as serum and plasma I-FABP. The definitive roles of I-FABP in early diagnosis of NEC, differential diagnosis in breast feeding, alimentary intolerance, and screening of surgical NEC need clarification and remain a challenge to investigators.</div></div>","PeriodicalId":17030,"journal":{"name":"Journal of Surgical Research","volume":"303 ","pages":"Pages 613-627"},"PeriodicalIF":1.8,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142502711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}